Analyte sensors and sensing methods for dual detection of glucose and ethanol

US12220235B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12220235-B2
Application numberUS-202016774909-A
CountryUS
Kind codeB2
Filing dateJan 28, 2020
Priority dateJan 28, 2019
Publication dateFeb 11, 2025
Grant dateFeb 11, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Multiple enzymes may be present in one or more active areas of an electrochemical analyte sensor for detecting one or more different analytes. In particular, an analyte sensor may comprise a sensor tail configured for insertion into a tissue and one or more working electrodes having a glucose-responsive active area and an ethanol-responsive active area to detect glucose and ethanol in vivo.

First claim

Opening claim text (preview).

What is claimed is the following: 1. An analyte sensor comprising: a) a working electrode; b) a glucose-responsive active area disposed upon a surface of the working electrode, the glucose-responsive active area comprising a glucose-responsive active enzyme capable of generating a first signal at the working electrode proportional to a glucose concentration; c) an ethanol-responsive active area comprising: i) a first active area disposed directly upon the surface of the working electrode spaced apart from the glucose-responsive active area, the first active area comprising xanthine oxidase and an electron transfer agent, in amounts sufficient to react with acetaldehyde to generate a second signal at the working electrode proportional to an alcohol concentration; and ii) a second active area isolated from the working electrode, the second active area comprising glucose oxidase and catalase in amounts sufficient to form acetaldehyde upon exposure to ethanol; d) a first membrane permeable to acetaldehyde disposed upon the first active area; and e) a second membrane permeable to glucose and ethanol disposed upon the glucose-responsive active area and the second active area, wherein the second active area is disposed directly upon the first membrane, and wherein the sensor is configured to be partially inserted into a user's skin. 2. The analyte sensor of claim 1 , wherein the first and second membranes comprise a polyvinylpyridine, a polyvinylimidazole, or any copolymer thereof. 3. The analyte sensor of claim 1 , wherein the first membrane comprises polyvinylpyridine and the second membrane comprises polyvinylpyridine-co-styrene. 4. The analyte sensor of claim 1 , wherein the xanthine oxidase is covalently bound to a first polymer, and the glucose oxidase is covalently bound to a second polymer. 5. The analyte sensor of claim 4 , wherein the electron transfer agent is covalently bound to the first polymer. 6. The analyte sensor of claim 5 , wherein the electron transfer agent comprises an osmium complex. 7. The analyte sensor of claim 1 , wherein the first active area further comprises catalase. 8. The analyte sensor of claim 1 , wherein the glucose-responsive enzyme is glucose oxidase or glucose dehydrogenase. 9. The analyte sensor of claim 1 , further comprising: a control module in communication with the analyte sensor and an electrical system of a vehicle, the control module including a computer system programmed to receive and process data provided by the analyte sensor, wherein operation of the vehicle is controlled or disabled by the computer system when a real-time measured analyte level of the operator crosses a predetermined safe threshold. 10. The analyte sensor of claim 1 , wherein the glucose-responsive active area further comprises a second electron transfer agent. 11. A method comprising: exposing an analyte sensor to a body fluid comprising at least one of glucose and ethanol, the analyte sensor comprising: a) a working electrode; b) a glucose-responsive active area disposed upon a surface of the working electrode, the glucose-responsive active area comprising a glucose-responsive active enzyme capable of generating a first signal at the working electrode proportional to a glucose concentration; c) an ethanol-responsive active area comprising: i) a first active area disposed directly upon the surface of the working electrode spaced apart from the glucose-responsive active area, the first active area comprising xanthine oxidase and an electron transfer agent, in amounts sufficient to react with acetaldehyde to generate a second signal at the working electrode proportional to an alcohol concentration; and ii) a second active area isolated from the working electrode, the second active area comprising glucose oxidase and catalase in amounts sufficient to form acetaldehyde upon exposure to ethanol; d) a first membrane permeable to acetaldehyde disposed upon the first active area; e) a second membrane permeable to glucose and ethanol disposed upon the glucose-responsive active area and the second active area, and detecting a first signal proportional to a glucose concentration and the second signal proportional to an ethanol concentration, wherein the second active area is disposed directly upon the first membrane, and wherein the sensor is configured to be partially inserted into a user's skin. 12. The method of claim 11 , wherein the glucose-responsive active area further comprises a second electron transfer agent.

Assignees

Inventors

Classifications

  • Toxicology, e.g. by detection of alcohol, drug or toxic products (A61B5/4848 takes precedence) · CPC title

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

  • actuating a signalling device (B60K28/063 takes precedence) · CPC title

  • responsive to incapacity of driver · CPC title

  • preventing starting of vehicles · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12220235B2 cover?
Multiple enzymes may be present in one or more active areas of an electrochemical analyte sensor for detecting one or more different analytes. In particular, an analyte sensor may comprise a sensor tail configured for insertion into a tissue and one or more working electrodes having a glucose-responsive active area and an ethanol-responsive active area to detect glucose and ethanol in vivo.
Who is the assignee on this patent?
Abbott Diabetes Care Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/14532. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).